Skip to main content
Top
Published in: European Archives of Paediatric Dentistry 5/2019

Open Access 01-10-2019 | Bisphosphonate | Original Scientific Article

Challenges of delivery of dental care and dental pathologies in children and young people with osteogenesis imperfecta

Authors: R. Clark, C. P. Burren, R. John

Published in: European Archives of Paediatric Dentistry | Issue 5/2019

Login to get access

Abstract

Background

Osteogenesis imperfecta (OI) is the most common inherited disorder of bone fragility in children, increasing fracture risk 100-fold and can feature dental and facial bone involvement causing additional morbidities.

Aim

To assess the utilisation of tertiary dental services by children and young people with OI attending a supra-regional multi-disciplinary OI service and review of the pathology identified and interventions undertaken.

Design

Case notes review of the current caseload of children and young people (0–18 years) with OI at a large regional OI specialist centre (n = 92). Primary outcome was whether an initial dental assessment was arranged in a tertiary dental centre and the corresponding attendance.

Results

49% had a tertiary dental assessment arranged, of whom 82% attended (one quarter requiring several appointments) and 18% did not attend (DNA).Those travelling > 100 miles had a DNA rate of 47%. Assessed children had dentinogenesis imperfecta (24%, 50% in Type III OI), radiographs (95%), caries (41%), required extraction under general anaesthesia (38%) and malocclusion (30%). 48% of the total cohort received bisphosphonates.

Conclusion

Tertiary dental assessment encountered barriers to uptake of recommended referral in all patients, often due to geographic factors of travel distance, yet when implemented did identify pathology in a large proportion and many resulted in dental intervention. These emphasise the relevance of specialist dental assessment in OI, particularly in the modern context of increased use of bisphosphonates. This is challenging to achieve and several models of delivery of care may need to be considered in this chronic childhood condition.
Appendix
Available only for authorised users
Literature
go back to reference Abukabbos H, Ali-Sineedi F. Clinical manifestation and dental management of dentinogenesis imperfecta associated with osteogenesis imperfecta. Saudi Dent. J. 2013;25:159–65.CrossRef Abukabbos H, Ali-Sineedi F. Clinical manifestation and dental management of dentinogenesis imperfecta associated with osteogenesis imperfecta. Saudi Dent. J. 2013;25:159–65.CrossRef
go back to reference Barron MJ, McDonnell ST, Mackie I, Dixon MJ. Hereditary dentine disorders—dentinogenesis imperfecta and dentine dysplasia. Orphanet J Rare Dis. 2008;31:10–8. Barron MJ, McDonnell ST, Mackie I, Dixon MJ. Hereditary dentine disorders—dentinogenesis imperfecta and dentine dysplasia. Orphanet J Rare Dis. 2008;31:10–8.
go back to reference Ben Amor IM, Roughley P, Glorieux FH, Rauch F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res. 2013;28:2001–7.CrossRef Ben Amor IM, Roughley P, Glorieux FH, Rauch F. Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1. J Bone Miner Res. 2013;28:2001–7.CrossRef
go back to reference Bhatt RN, Hibbert SA, Munns CF. The use of bisphosphonates in children: review of the literature and guidelines for dental management. Aust Dent J. 2014;59:9–19.CrossRef Bhatt RN, Hibbert SA, Munns CF. The use of bisphosphonates in children: review of the literature and guidelines for dental management. Aust Dent J. 2014;59:9–19.CrossRef
go back to reference Bradaschia-Correa V, Massa LF, Arana-Chavez VE. Effects of alendronate on tooth eruption and molar root formation in young, growing rats. Cell Tissue Res. 2007;330:475–85.CrossRef Bradaschia-Correa V, Massa LF, Arana-Chavez VE. Effects of alendronate on tooth eruption and molar root formation in young, growing rats. Cell Tissue Res. 2007;330:475–85.CrossRef
go back to reference Christou J, Hodgson TA, Johnson AR. The Dental management of children on bisphosphonates therapy in the UK. Oral Diseas. 2012;18:3–48.CrossRef Christou J, Hodgson TA, Johnson AR. The Dental management of children on bisphosphonates therapy in the UK. Oral Diseas. 2012;18:3–48.CrossRef
go back to reference Christou J, Johnson AR, Hodgson TA. Bisphosphonate-related osteonecrosis of the jaws and its relevance to children—a review. Int J Pediatr Dent. 2013;23:330–7.CrossRef Christou J, Johnson AR, Hodgson TA. Bisphosphonate-related osteonecrosis of the jaws and its relevance to children—a review. Int J Pediatr Dent. 2013;23:330–7.CrossRef
go back to reference Engelbert RH, Uiterwaal CS, Gerver WJ, et al. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with a 4 year follow up. Arch Phys Med Rehabil. 2004;85:772–8.CrossRef Engelbert RH, Uiterwaal CS, Gerver WJ, et al. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with a 4 year follow up. Arch Phys Med Rehabil. 2004;85:772–8.CrossRef
go back to reference Esposito P, Plotkin H. Surgical treatment of osteogenesis imperfecta: current concepts. Curr Opin Pediatr. 2008;20:52–7.CrossRef Esposito P, Plotkin H. Surgical treatment of osteogenesis imperfecta: current concepts. Curr Opin Pediatr. 2008;20:52–7.CrossRef
go back to reference Iglesias-Linares A, Yanez-Vico RM, Solano-Reina E, Torres-Lagares D, Gonzalez-Moles MA. Influence of bisphosphonates in orthodontic therapy: systematic review. J Dent. 2010;38:603–11.CrossRef Iglesias-Linares A, Yanez-Vico RM, Solano-Reina E, Torres-Lagares D, Gonzalez-Moles MA. Influence of bisphosphonates in orthodontic therapy: systematic review. J Dent. 2010;38:603–11.CrossRef
go back to reference Imbert L, Auregan JC, Pernelle K, Hoc T. Mechanical and mineral properties of osteogenesis imperfecta human bone at the tissue level. Bone. 2014;65:18–24.CrossRef Imbert L, Auregan JC, Pernelle K, Hoc T. Mechanical and mineral properties of osteogenesis imperfecta human bone at the tissue level. Bone. 2014;65:18–24.CrossRef
go back to reference Jensen BL, Lund AM. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV. J Craniofac Genet Dev Biol. 1997;17:121–32.PubMed Jensen BL, Lund AM. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV. J Craniofac Genet Dev Biol. 1997;17:121–32.PubMed
go back to reference Khan AA, Sandor GK, Dore E, et al. Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2009;36:478–90.CrossRef Khan AA, Sandor GK, Dore E, et al. Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2009;36:478–90.CrossRef
go back to reference Malmgren B, Astrom E, Soderhall S. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med. 2008;37:196–200.CrossRef Malmgren B, Astrom E, Soderhall S. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J Oral Pathol Med. 2008;37:196–200.CrossRef
go back to reference Marini JC, Blissett AR. New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013;98:3095CrossRef Marini JC, Blissett AR. New genes in bone development: what's new in osteogenesis imperfecta. J Clin Endocrinol Metab. 2013;98:3095CrossRef
go back to reference O’Connell AC, Marini JC. Evaluation of Oral Problems in Osteogenesis Imperfecta. J Oral Surg Oral Med Oral Path Oral Rad Oral Endo. 1999;87:189–96.CrossRef O’Connell AC, Marini JC. Evaluation of Oral Problems in Osteogenesis Imperfecta. J Oral Surg Oral Med Oral Path Oral Rad Oral Endo. 1999;87:189–96.CrossRef
go back to reference Okawa R, Kubota T, Kitaoka T, et al. Oral manifestations of Japanese patients with osteogenesis imperfecta. Paediatr Dental J. 2017;27:73–8.CrossRef Okawa R, Kubota T, Kitaoka T, et al. Oral manifestations of Japanese patients with osteogenesis imperfecta. Paediatr Dental J. 2017;27:73–8.CrossRef
go back to reference Patel RM, Nagamani SC, Cuthbertson D, et al. A cross sectional multi-centred study of osteogenesis imperfecta in North America. Clin Genet. 2015;87:133–40.CrossRef Patel RM, Nagamani SC, Cuthbertson D, et al. A cross sectional multi-centred study of osteogenesis imperfecta in North America. Clin Genet. 2015;87:133–40.CrossRef
go back to reference Rizkallah J, Schwartz S, Rauch F, et al. Evaluation of the severity of malocclusion in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy index. Am J Orthod Dentofac Orthop. 2012;143:336–41.CrossRef Rizkallah J, Schwartz S, Rauch F, et al. Evaluation of the severity of malocclusion in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy index. Am J Orthod Dentofac Orthop. 2012;143:336–41.CrossRef
go back to reference Rosen A, Modig M, Larson O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Maxillofac Surg. 2011;40:866–86.CrossRef Rosen A, Modig M, Larson O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Maxillofac Surg. 2011;40:866–86.CrossRef
go back to reference Sapir S, Shapira J. Clinical solutions for developmental defects of enamel and dentine in children. Pediatr Dent. 2007;29:330–6.PubMed Sapir S, Shapira J. Clinical solutions for developmental defects of enamel and dentine in children. Pediatr Dent. 2007;29:330–6.PubMed
go back to reference Shields ED, Bixler D, El-Kafrawy AM. A proposed classification for heritable human dentine defects with a description of a new entity. Arch Oral Biol. 1973;18:543–53.CrossRef Shields ED, Bixler D, El-Kafrawy AM. A proposed classification for heritable human dentine defects with a description of a new entity. Arch Oral Biol. 1973;18:543–53.CrossRef
go back to reference Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101–16.CrossRef Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101–16.CrossRef
go back to reference Teixeira CS, Santos-Felippe MCS, Tadeu-Felippe WT. The role of dentists in diagnosing osteogenesis imperfecta in patients with dentinogenesis imperfecta. J Am Dent Assoc. 2008;139:906–14.CrossRef Teixeira CS, Santos-Felippe MCS, Tadeu-Felippe WT. The role of dentists in diagnosing osteogenesis imperfecta in patients with dentinogenesis imperfecta. J Am Dent Assoc. 2008;139:906–14.CrossRef
go back to reference Trejo P, Rauch F. Osteogenesis imperfecta in children and adolescents—new developments in diagnosis and treatment. Osteoporos Int. 2016;27:427–37.CrossRef Trejo P, Rauch F. Osteogenesis imperfecta in children and adolescents—new developments in diagnosis and treatment. Osteoporos Int. 2016;27:427–37.CrossRef
go back to reference Tsakos G, Hill K, Chadwick B, Anderson T. Children’s dental health survey 2013. Attitudes, behaviours and children’s dental health. England, Wales and Northern Ireland, HSCIC, 2015. 2013 Tsakos G, Hill K, Chadwick B, Anderson T. Children’s dental health survey 2013. Attitudes, behaviours and children’s dental health. England, Wales and Northern Ireland, HSCIC, 2015. 2013
go back to reference Uday S, Gaston CL, Rogers L, et al. Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumour of bone. J Clin Endocrinol Metab. 2018;103:596–603.CrossRef Uday S, Gaston CL, Rogers L, et al. Osteonecrosis of the jaw and rebound hypercalcemia in young people treated with denosumab for giant cell tumour of bone. J Clin Endocrinol Metab. 2018;103:596–603.CrossRef
go back to reference Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164:1470–81.CrossRef Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164:1470–81.CrossRef
go back to reference Vuorimies I, Arponen H, Valta H, et al. Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment. Bone. 2017;94:29–33.CrossRef Vuorimies I, Arponen H, Valta H, et al. Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment. Bone. 2017;94:29–33.CrossRef
Metadata
Title
Challenges of delivery of dental care and dental pathologies in children and young people with osteogenesis imperfecta
Authors
R. Clark
C. P. Burren
R. John
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Paediatric Dentistry / Issue 5/2019
Print ISSN: 1818-6300
Electronic ISSN: 1996-9805
DOI
https://doi.org/10.1007/s40368-019-00424-w

Other articles of this Issue 5/2019

European Archives of Paediatric Dentistry 5/2019 Go to the issue